ロード中...
Enhancing CHK1 inhibitor lethality in glioblastoma
The present studies were initiated to determine whether inhibitors of MEK1/2 or SRC signaling, respectively, enhance CHK1 inhibitor lethality in primary human glioblastoma cells. Multiple MEK1/2 inhibitors (CI-1040 (PD184352); AZD6244 (ARRY-142886)) interacted with multiple CHK1 inhibitors (UCN-01,...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3341214/ https://ncbi.nlm.nih.gov/pubmed/22313687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.19240 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|